NetAlly Taps Channel Veteran Jeff McCullough to Drive Partner Sales Growth Across North America

COLORADO SPRINGS, Colo., Oct. 15, 2024 (GLOBE NEWSWIRE) — NetAlly, the leader in handheld network test for wired, wireless and edge security vulnerabilities, today announced the appointment of Jeff McCullough as its Vice President of Sales, North America. In addition to leading North American sales teams, McCullough is tasked with driving revenue growth for NetAlly, […]

Local Falcon Introduces Falcon Guard: Safeguarding Google Business Listings Against Unauthorized Changes

Erie, PA, Oct. 15, 2024 (GLOBE NEWSWIRE) — Local Falcon, a global leader in local search analysis, is proud to announce the launch of Falcon Guard, an innovative listing change monitoring tool designed to protect businesses from malicious edits to their Google Business Profiles. Falcon Guard offers monitoring for multiple business locations, providing an unmatched

Annexon to Present New Phase 2 ARCHER Data for ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting

ANX007 Demonstrated Significant Vision Protection in Standard and Low Light Conditions and Significant Photoreceptor Preservation in the Fovea Region Critical for Visual Acuity Phase 3 Data from Ongoing ARCHER II Pivotal Program Expected Second Half 2026 BRISBANE, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company focused on upstream C1q

Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer

– Immuneering recently announced positive initial Phase 2a data, including complete and partial responses, with IMM-1-104 in combination with chemotherapy in first-line pancreatic cancer patients – -Initial data from at least one additional arm of the Phase 2a portion of the Company’s Phase 1/2a trial is expected by year-end – CAMBRIDGE, Mass., Oct. 15, 2024

WALKER RIVER ANNOUNCES ADDITIONAL RESULTS FROM THE LAPON GOLD PROJECT

// THIS PRESS RELEASE IS NOT INTENDED FOR RELEASE OR DISSEMINATION IN THE UNITED STATES // Vancouver, B.C., Oct. 15, 2024 (GLOBE NEWSWIRE) — Walker River Resources Corp. (“Walker” or the “Company“) (TSX-V: WRR) is pleased to announce additional assay results from the 2024 reverse circulation (“RC“) drill program at Lapon Canyon, along with assays

IPG Photonics to Announce Third Quarter 2024 Financial Results on October 29

MARLBOROUGH, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) — IPG Photonics Corporation (Nasdaq: IPGP) will release its third quarter 2024 financial results before the market opens on Tuesday, October 29, 2024. The Company will hold a conference call to review these results at 10:00 a.m. ET on the same day. To access the call, please dial

More Than One-Third of Gig Workers Rely on Gig Work as Primary Source of Income

CHICAGO, Oct. 15, 2024 (GLOBE NEWSWIRE) — While consumers have grown accustomed to on-demand services, like ridesharing and food delivery, they are also increasingly open to participating in the gig economy as workers. More than half of U.S. adults (62%) now earn money working for one or more gig platforms, according to new TransUnion (NYSE:

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

VANCOUVER, Wash. and NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the third quarter before market open on Tuesday, November 12, 2024. Absci management will webcast a corresponding conference call

Core Molding Technologies Announces Timing of Third Quarter Fiscal Year 2024 Results

COLUMBUS, Ohio, Oct. 15, 2024 (GLOBE NEWSWIRE) — Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, utilities, transportation and powersports industries across North America, today announces that it will release its third quarter fiscal year 2024

atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit

NEW YORK and BERLIN, Oct. 15, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that Srinivas Rao, M.D., Ph.D., the Company’s Co-founder and Co-CEO, is scheduled to participate in the 2024 Maxim Healthcare Virtual Summit taking

Scroll to Top